Biotest Delisting from Frankfurt Stock Exchange Following Grifols’ Public Tender Offer

Ashurst has advised Biotest AG on the deal.Biotest AG has entered into a delisting agreement with GRIFOLS, S.A., as part of a public delisting tender offer…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Marco Zingaro

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here